CRXT News and Press, Clarus Therapeutics Holdings Inc. From 11/23/21

When you look for different penny stocks to buy, what do you look for? In most cases, you’re seeking out a catalyst to understand why certain stocks might move or are in the process of moving. Today we focus on precisely that. Whether it’s stock market news, company-specific h...

Clarus Therapeutics Holdings, Inc. (CRXT) Q3 2021 Earnings Conference Call November 18, 2021 5:15 PM ET Company Participants Bob Dudley – President and Chief Executive Officer Ric Peterson – Chief Financial Officer Frank Jaeger – Chief Commercial Officer Steven Bourne &#x...

Clarus Therapeutics (NASDAQ:CRXT): Q3 GAAP EPS of -$0.26. Revenue of $4.28M (+92.8% Y/Y) Press Release For further details see: Clarus Therapeutics reports Q3 results

Third quarter 2021 revenue increased 93% year-over-year to $4.3 million Third quarter 2021 total prescription growth for JATENZO ® increased 12% sequentially and 132% year-over-year Conference call and webcast today at 5:15 p.m. ET NORTHBROOK, Ill., No...

NORTHBROOK, Ill., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced it...

Shares of recently IPO’ed Clarus Therapeutics (CRXT +56.0%) has surged over 50%, recording the biggest intra-day gain since the commercial-stage pharma company went public thanks to a SPAC deal with Blue Water Acquisition Corp. Over 16M Clarus (NASDAQ:CRXT) shares have change...

Gainers: Evaxion Biotech A/S EVAX +148%. Clarus Therapeutics Holdings (NASDAQ:CRXT) +50%. Cassava Sciences SAVA +45%. NeoPhotonics NPTN +38%. Harbor Custom Development (NASDAQ:HCDI) +26%. Big 5 Sporting Goods BGFV +26%. TDH Holdings (NASDAQ:PETZ) +25%. Yellow YELL ...

JATENZO® (testosterone undecanoate) is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in adult males who have deficient testosterone due to certain medical conditions Upon issuance, Clarus plans to list these patents in FDA’s ...

Gainers: 23andMe Holding (NASDAQ:ME) +13%. Performant Financial Corporation (NASDAQ:PFMT) +4%. G1 Therapeutics (NASDAQ:GTHX) +3%. Kala Pharmaceuticals (NASDAQ:KALA) +3%. Avadel Pharmaceuticals  (NASDAQ:AVDL) +3%. Losers: Duck Creek Technologies DCT -10%. Corsair Gaming CRS...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 14, 2021 – USA News Group –  Compared to the Dow Jones Industrial Average which has gained an impressive 10.6% through Q3 2021, and the S&P 500 and Nasdaq doing ev...